Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesar U Monjaras-Avila

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Scientific Reports|October 9, 2024
Evaluating different methods for kidney recellularizationAna C Luque-Badillo, Cesar U Monjaras-Avila, Hans Adomat, et al.
International Journal of Molecular Sciences|May 13, 2023
The Tumor Immune Microenvironment in Clear Cell Renal Cell CarcinomaCesar U Monjaras-Avila, Ana C Lorenzo-Leal, Ana C Luque-Badillo, et al.
Scientific Reports|February 8, 2020
Identification of gene signature for treatment response to guide precision oncology in clear-cell renal cell carcinomaNinadh M D'Costa, Davide Cina, Raunak Shrestha, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 12, 2020
Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinomaNinadh M D'Costa, Matthew R Lowerison, Peter A Raven, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Scientific Reports|October 9, 2024
Evaluating different methods for kidney recellularizationAna C Luque-Badillo, Cesar U Monjaras-Avila, Hans Adomat, et al.
International Journal of Molecular Sciences|May 13, 2023
The Tumor Immune Microenvironment in Clear Cell Renal Cell CarcinomaCesar U Monjaras-Avila, Ana C Lorenzo-Leal, Ana C Luque-Badillo, et al.
Scientific Reports|February 8, 2020
Identification of gene signature for treatment response to guide precision oncology in clear-cell renal cell carcinomaNinadh M D'Costa, Davide Cina, Raunak Shrestha, et al.
Journal of Experimental & Clinical Cancer Research : CR|February 12, 2020
Y-box binding protein-1 is crucial in acquired drug resistance development in metastatic clear-cell renal cell carcinomaNinadh M D'Costa, Matthew R Lowerison, Peter A Raven, et al.
Pageof 1